Moderna

-$7.13 (-4.97%) Today
-$0.25 (-0.18%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

CEO
Stéphane Bancel
Employees
2,700
Headquarters
Cambridge, Massachusetts
Founded
2010

MRNA Key Statistics

Market cap
54.19B
Price-Earnings ratio
4.22
Dividend yield
—
Average volume
6.79M
High today
$144.77
Low today
$131.39
Open price
$142.56
Volume
5.88M
52 Week high
$497.49
52 Week low
$119.01

MRNA Earnings

-$0.69
$3.30
$7.30
$11.29
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure